Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

LLY has delivered impressive returns of 15% year-to-date, outperforming the S&P 500’s 5% decline during the same period. This ...

Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Musk has served Tesla well, but now the EV company needs someone like Tim Cook who thrives at fine-tuning processes.

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...

The company's cloud division is advising its frontline sales and technical staff on how to answer potential customer ... Johnson & Johnson, Eli Lilly, and SoftBank. Correction: Yesterday, we ...

President Donald Trump has signed executive orders to relax some of his 25% tariffs on automobiles and auto parts, a ...

Michael Minchak; Vice President of Investor Relations; Teladoc Health Inc. Charles Divita; Chief Executive Officer; Teladoc Health Inc. Mala Murthy; Chief Financial ...